Experimental Lilly Drug Cuts Genetic Heart Disease Risk Factor by 94% in Trial

By Julie SteenhuysenCHICAGO (Reuters) -The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a...

By Julie SteenhuysenCHICAGO (Reuters) -The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a...